Clinicopathological features and prognosis of patients with resectable HAS/GAED: A multicenter nested case–control study from China
Digestive and Liver Disease · 2026
DOI: 10.1016/j.dld.2026.02.004 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive and Liver Disease, 2026. Verfasst von Lihu Gu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Clinical Specialty-Oncology, National Key Clinical Specialty Discipline Construction Program of China, Science and Technology Innovation 2025 Major Project of Ningbo.
Abstract (Originalsprache)
BACKGROUND: Hepatoid adenocarcinoma of the stomach (HAS) and gastric adenocarcinoma with enteroblastic differentiation (GAED) are rare and highly aggressive subtypes of gastric cancer (GC). AIMS: This study aimed to investigate the clinicopathological characteristics and prognostic outcomes of patients with HAS and GAED. METHODS: This multicenter retrospective study compared 107 patients with HAS/GAED with 428 patients with conventional GC (cGC) after 4:1 propensity score matching (PSM). The primary outcomes included disease-free survival (DFS), gastric cancer-specific survival (GCSS), and overall survival (OS). Survival analyses were performed using Cox proportional hazards models and Kaplan-Meier curves. RESULTS: With a median follow-up of 33 months, patients in the HAS/GAED group, compared with those in the cGC group, exhibited larger tumor size, poorer histological differentiation, higher preoperative carcinoembryonic antigen (CEA) levels, and a higher rate of human epidermal growth factor receptor 2 (HER2) overexpression (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
- The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Ningbo Clinical Pathology Diagnosis Center Ningbo, Ningbo, Zhejiang, China.
- Cardiothoracic Surgery Department, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China.
- Medical Records Statistics Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
- Department of General Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Förderung
- National Key Clinical Specialty-Oncology
- National Key Clinical Specialty Discipline Construction Program of China
- Science and Technology Innovation 2025 Major Project of Ningbo
Zitieren
APA
Gu, L., Zhang, X., Ji, S., Pan, Y., Shen, Y., Zhang, M., Wu, Q., Yu, W., Wu, F., & Zheng, Q. (2026). Clinicopathological features and prognosis of patients with resectable HAS/GAED: A multicenter nested case–control study from China. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.02.004
Vancouver
Gu L, Zhang X, Ji S, Pan Y, Shen Y, Zhang M, et al. Clinicopathological features and prognosis of patients with resectable HAS/GAED: A multicenter nested case–control study from China. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.02.004
BibTeX
@article{Gu2026,
author = {Gu, Lihu and Zhang, Xiaoming and Ji, Shengqiang and Pan, Yihang and Shen, Yi and Zhang, Moucheng and Wu, Qingping and Yu, Weiming and Wu, Feng and Zheng, Qi},
title = {Clinicopathological features and prognosis of patients with resectable HAS/GAED: A multicenter nested case–control study from China},
journal = {Digestive and Liver Disease},
year = {2026},
doi = {10.1016/j.dld.2026.02.004}
}
EUVIMED